ArticleTherapeutic advances in respiratory disease

Advanced therapeutic inhalation aerosols of a Nrf2 activator and RhoA/Rho kinase (ROCK) inhibitor for targeted pulmonary drug delivery in pulmonary hypertension: design, characterization, aerosolization,

Maria F Acosta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.